ClinicalTrials.gg
CompletedNCT03139864DIABSPORTUpdated Nov 17, 2026

Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.

An interventional study of controlled physical activity in Type 1 Diabetes, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Prevention

How we know

Updated Nov 17, 2026Now CompletedResults publication added+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Non-randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 271 studies in Diabetes Mellitus, Type 1 with a site in France — 39 open to participants now, 45 under way, 8 of them phase 3. Diabetes Mellitus, Type 1 · France.

Enrollment
117th of 193
48 · median 67
Started
2017
with 10 others
No phase
103 of 271
9 open now
Registered
137th of 271
by date

Among the 271 studies in Diabetes Mellitus, Type 1 with a site in France, this one is the 117th largest by enrollment of the 193 interventional ones that give a count, is one of 11 that started in 2017, is one of 103 with no phase, and was the 137th registered.

Diabetes Mellitus, Type 1

3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.

Browse Diabetes Mellitus, Type 1 studies →

Open to participants now

39 of the 271 studies in Diabetes Mellitus, Type 1 with a site in France are open now. Recruiting first, the newest first:

34 more — sign in →

All 39 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 271 studies in Diabetes Mellitus, Type 1 with a site in France, or all of them as a file.
02

Study summary

The type 1 diabetes is a common chronic disease characterised by the stop of production of insulin by the pancreas. A lot of factors modify blood glucose. The objective is to study the effect of type 1 diabetes on the use of energy substrates (fats and carbohydrates) during exercise of increasing intensity by a comparison with non-diabetic controls children.

Read the detailed description

The type 1 diabetes is a common chronic disease characterised by the stop of production of insulin by the pancreas. A lot of factors modify blood glucose. The objective is to study the effect of type 1 diabetes on the use of energy substrates (fats and carbohydrates) during exercise of increasing intensity by a comparison with non-diabetic controls children.

03

Conditions studied

  • Type 1 Diabetes

Keywords

  • Type 1 diabetes
  • Control
  • Physical activity
  • Substrate utilization
  • Hormonal regulation
04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children between 6 and 12 years
  • Tanner stage \<T2
  • Type 1 diabetes for more than 1 year for infants with type 1 diabetes

Exclusion criteria

Exclusion Criteria:

  • Tanner stage > ou = T2
  • Obesity
  • Hormonal disease
  • Disease who prevent doing exercise
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    type 1 diabetes

    Comparison between infants with type 1 diabetes and infants without type 1 diabetes during exercise :

    Procedure: controlled physical activity

  • Active comparator
    without type 1 diabetes

    Comparison between infants with type 1 diabetes and infants without type 1 diabetes during exercise :

    Procedure: controlled physical activity

Interventions

  • Procedurecontrolled physical activity

    Comparison between infants with type 1 diabetes and infants without type 1 diabetes during exercise :

06

What researchers measure

Primary outcomes

  1. Comparison of substrate utilization between infants with type 1 diabetes and infants without type 1 diabetes during exercise

    Measurements will be carried out by indirect calorimetry and the relationship between CO2 et O2 (Metamax)

    Time frame: at day 1

Secondary outcomes

  1. hormonal regulation of blood glucose

    insulin, glucagon, adrenaline, cortisol and growth hormone will be metered according to their half life until 2 hours after physical activity (T12, T20, T40, T60, T120)

    Time frame: at day 1

  2. lipoxmax : the intensity for wich lipid oxydation is maximum will be carried out by indirect calorimetry

    during exercise

    Time frame: at day 1

  3. Comparison between infants during 10 days before and 4 days after exercise of blood glucose modification

    Comparison of curves of interstitial blood glucose measured with Freestyle®

    Time frame: 10 days before and 4 days after exercise of blood glucose modification

07

Study locations

1 site
  • CHU Clermont-Ferrand
    Clermont-Ferrand, 63003, France
08

References and documents

Publications

  • Fel S, Rochette E, Walther G, Echaubard S, Pereira B, Merlin E, Terral D, Duche P. Maximal Fat Oxidation During Exercise Is Already Impaired in Pre-pubescent Children With Type 1 Diabetes Mellitus. Front Physiol. 2021 Apr 9;12:664211. doi: 10.3389/fphys.2021.664211. eCollection 2021. PubMed 33897473 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2017 to primary completion in Apr 2018, 12 months.

Of 852 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's 12 months is below that.

Counting every sponsor, half of 957 studies reached it within 18 months; a quarter within 9 and three quarters within 35.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion May 2019 → Apr 2018 and completion Dec 2019 → Nov 2018.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2017
First posted
May 4, 2017
StartActual
Apr 4, 2017
Primary completionActual
Apr 4, 2018was May 2019
CompletionActual
Nov 4, 2018was Dec 2019
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 17, 2026
Primary completion
May 2019→Apr 4, 2018 (actual)
Nov 17, 2026
Study completion
Dec 2019→Nov 4, 2018 (actual)
Nov 17, 2026
Publications
Results publication added: Fel S, Rochette E, Walther G, Echaubard S, Pereira B, Merlin E, Terral D, Duche P. Maximal Fat Oxidation During Exercise Is Already Impaired in Pre-pubescent C… PubMed 33897473 ↗
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Status unknown→Completed
    Publications Results publication added: Fel S, Rochette E, Walther G, Echaubard S, Pereira B, Merlin E, Terral D, Duche P. Maximal Fat Oxidation During Exercise Is Already Impaired in Pre-pubescent C… PubMed 33897473 ↗
    Primary completion May 2019→Apr 4, 2018 (now actual)
    Study completion Dec 2019→Nov 4, 2018 (now actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03139864
Responsible party
Sponsor
First posted
May 4, 2017
Start date
Apr 4, 2017
Primary completion
Apr 4, 2018
Completion
Nov 4, 2018
Last update
Nov 17, 2026

Study contacts

Daniel TERRAL
principal investigator · University Hospital, Clermont-Ferrand

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion